Yuan Goessi: One Bleed Is One Too Many for a Lifetime of Haemophilia A
Yuan Goessi, Digital Marketing Intern at Roche, shared a post on LinkedIn:
“At the heart of every discussion about the future of haemophilia A is the recognition that redefining care goes beyond medicine – it is about looking at patients’ whole lives, protecting joint health, and easing the daily anxieties that families carry across generations.
At Roche, we believe that even one bleed is one too many, especially for a condition like haemophilia A that is for life.
We are profoundly grateful to the dedicated clinicians, researchers, and patient organisations who partner with us every day.
Together, we are raising the bar to turn scientific progress into a new reality.
Find out more about our efforts in haemophilia A on our website.”
Procees to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments